|
Market Closed -
Nasdaq
04:00:00 31/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 1.420 USD | -4.05% |
|
-.--% | +23.48% |
| Market Cap | 632M 566M 521M 472M 882M 59.99B 898M 6.21B 2.49B 31.56B 2.37B 2.32B 99.52B | P/E 2026 * |
-8.35x | P/E 2027 * | -7.1x |
|---|---|---|---|---|---|
| Enterprise Value | 632M 566M 521M 472M 882M 59.99B 898M 6.21B 2.49B 31.56B 2.37B 2.32B 99.52B | EV / Sales 2026 * |
17x | EV / Sales 2027 * | 37.3x |
| Free-Float |
98.45% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| LXRX | Delayed | |
CBOE
| LXRX | Real-time | |
|
Tradegate
| LX31 | Real-time |
Last Transcript: Lexicon Pharmaceuticals, Inc.
| 1 day | -4.05% | ||
| 1 month | -24.27% | ||
| 3 months | -38.53% | ||
| 6 months | -11.80% | ||
| Current year | +23.48% |
| 1 week | 1.38 |  | 1.52 |
| 1 month | 1.36 | | 1.87 |
| Current year | 1.1 | | 2.68 |
| 1 year | 1.1 | | 2.68 |
| 3 years | 0.28 | | 3.73 |
| 5 years | 0.28 | | 5.79 |
| 10 years | 0.28 | | 18 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Exton
CEO | Chief Executive Officer | 56 | 08/07/2024 |
Scott Coiante
DFI | Director of Finance/CFO | 59 | 02/01/2025 |
Michael Davies
CTO | Chief Tech/Sci/R&D Officer | - | 01/02/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Samuel Barker
CHM | Chairman | 83 | 01/01/2005 |
Ray Debbane
CHM | Chairman | 71 | 27/02/2012 |
| Director/Board Member | 67 | 28/08/2007 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/6/26 | Exercice | Director | 178,624 | 0.0402% | ||
| 3/6/26 | Exercice | Director | 178,624 | 0.0402% | ||
| 3/6/26 | Exercice | Director | 178,624 | 0.0402% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.05% | -.--% | +2.90% | +14.52% | 632M | |
| -0.62% | -1.87% | +42.87% | +64.15% | 63.77B | |
| +0.35% | +3.20% | +14.40% | +81.76% | 56.37B | |
| +0.53% | +1.96% | +16.24% | +103.35% | 54.62B | |
| -2.81% | -4.31% | +23.50% | +47.83% | 44.06B | |
| -0.33% | -1.93% | +19.28% | +98.80% | 42.11B | |
| +0.55% | +2.31% | +225.14% | +866.21% | 41B | |
| +3.27% | +47.96% | +112.84% | +96.58% | 34.92B | |
| +1.22% | -1.44% | +14.57% | +46.95% | 32.82B | |
| +0.89% | +20.55% | -40.62% | +349.24% | 24.7B | |
| Average | -0.10% | +6.79% | +43.11% | +176.94% | 39.5B | |
| Weighted average by Cap. | +0.17% | +5.43% | +47.92% | +176.41% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 37.17M 33.29M 30.62M 27.75M 51.87M 3.53B 52.84M 365M 147M 1.86B 140M 137M 5.86B | 16.93M 15.16M 13.95M 12.64M 23.62M 1.61B 24.06M 166M 66.76M 845M 63.53M 62.18M 2.67B |
| Net income | -73.77M -66.07M -60.77M -55.06M -103M -7B -105M -725M -291M -3.68B -277M -271M -11.62B | -97.05M -86.92M -79.95M -72.44M -135M -9.21B -138M -953M -383M -4.85B -364M -356M -15.29B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/10/26 | US$1.420 | -4.05% | 2,444,205 |
| 29/10/26 | US$1.480 | -0.34% | 1,772,640 |
| 28/10/26 | US$1.485 | +0.34% | 1,618,937 |
| 27/10/26 | US$1.480 | +2.07% | 1,861,649 |
| 26/10/26 | US$1.450 | +2.11% | 2,205,901 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LXRX Stock
Select your edition
All financial news and data tailored to specific country editions
